Last Updated on February 29, 2016 by Joseph Gut – thasso February 26, 2016 – Two new treatments for oncologic indications have been approved by the American Food and Drug Administration (FDA). Thus, the FDA approved Obinutuzumab (Gazyva) for use in combination with bendamustine …

News for Obinutuzumab (Gazyva) and Everolimus (Afinitor) Read more »

Last Updated on February 19, 2016 by Joseph Gut – thasso  February 19, 2016 – Epilepsy is a brain disorder that causes people to have recurring seizures. A seizure is an episode, usually of relatively short duration, of abnormal brain activity. Seizures …

Epilepsy: Brivaracetam (Briviact) approved for the treatment of partial onset seizures Read more »

Last Updated on February 14, 2016 by Joseph Gut – thasso February 14, 2016 – Diabetic ketoacidosis is a serious complication of diabetes caused by low insulin levels. Rare cases of this condition, including life-threatening ones, have occurred in patients taking …

SGLT2 inhibitors and diabetic ketoacidosis: PRAC makes recommendations to minimise risk to patients Read more »

Last Updated on February 12, 2016 by Joseph Gut – thasso February 4, 2016 – This article is relied from FDA’s press release section and only very sightly edited.  In response to the rampant opioid abuse epidemic in the United States …

The rampant opioid epidemic: FDA officials call for sweeping review of agency opioids policies Read more »

Last Updated on February 7, 2016 by Joseph Gut – thasso February 07, 2016 – The European Commission has approved once-daily Osimertinib (Tagrissa) for the treatment of patients with locally advanced or metastatic non-small-cell lung cancer (NSCLC) that is positive for …

Osimertinib (Tagrissa) approved for non-smal cell lung cancer (NSCLC) patient subgroup carrying the EGFR T790M mutation Read more »

Last Updated on August 1, 2016 by Joseph Gut – thasso February 04, 2016 – Genetic variations on a stretch of chromosome may predict responsiveness among patients with bipolar disorder to the mood stabilizing drug lithium (multiple brands), a genome-wide analysis …

Genetic Variants Predict Lithium Response in Bipolar Disorder Read more »